MedPath

CHILDREN'S HOSPITAL KARACHI

🇵🇰Pakistan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients

Phase 2
Completed
Conditions
Thalassemia, Beta
Interventions
First Posted Date
2023-12-01
Last Posted Date
2023-12-01
Lead Sponsor
Children's Hospital Karachi
Target Recruit Count
603
Registration Number
NCT06153784
Locations
🇵🇰

Children's Hospital Karachi, Karachi, Sindh, Pakistan

Clinical Experience of Thalidomide in Thalassemic Patients

Phase 2
Completed
Conditions
Thalassemia, Beta
Interventions
First Posted Date
2021-11-24
Last Posted Date
2021-11-24
Lead Sponsor
Children's Hospital Karachi
Target Recruit Count
135
Registration Number
NCT05132270
Locations
🇵🇰

Children's Hospital Karachi, Karachi, Sindh, Pakistan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.